中国区域移动SARS-CoV-2病毒核酸检测能力评估指标体系:一项改良德尔菲共识研究
该研究基于大量文献与专家访谈形成初始版评估指标体系,设计德尔菲法问卷,对30名专家进行两轮咨询以筛选和修订三级指标,并采用层次分析法计算各级指标权重。结果建成包含5项一级指标、17项二级指标、90项三级指标的区域移动SARS-CoV-2核酸检测能力评估体系,两轮问卷回收率分别为100%和96.7%,30名专家权威系数为0.71,肯德尔协调系数差异有统计学意义(P < 0.001)。一级指标权重中「人员队伍建设」为0.2046居首,其后依次为「实验室性能建设与维护」0.2023、「应急响应保障」0.1989、「核酸检测资源信息管理系统」0.1982、「区域移动核酸检测应急响应体系建设」0.1959。作者认为该体系提出具体、客观、可量化的评估标准,可作为多元化主体发现薄弱环节和漏洞的工具,并为主管部门提升核酸检测能力提供可测量依据。
要点
- 评估体系含5项一级、17项二级、90项三级指标,两轮德尔菲咨询问卷回收率分别为100%和96.7%。
- 30名专家权威系数为0.71,肯德尔协调系数差异有统计学意义(P < 0.001)。
- 一级指标权重:「人员队伍建设」0.2046居首,其次「实验室性能建设与维护」0.2023、「应急响应保障」0.1989。
- 其余一级指标权重:「核酸检测资源信息管理系统」0.1982、「区域移动核酸检测应急响应体系建设」0.1959。
- 作者认为该体系可作为多元化主体发现薄弱环节和漏洞、主管部门提升核酸检测能力的可测量工具。
研究设计与关键结果
- 研究类型:改良德尔菲共识研究;基于大量文献与专家访谈确定初始版评估指标体系。
- 对30名专家进行两轮德尔菲法问卷咨询,以筛选和修订三级指标;采用层次分析法计算各级指标权重。
- 最终形成区域移动SARS-CoV-2核酸检测能力评估体系,包括5项一级指标、17项二级指标、90项三级指标。
- 两轮问卷回收率分别为100%和96.7%;30名专家权威系数为0.71;肯德尔协调系数差异有统计学意义(P < 0.001)。
- 按一致性检验确定各级能力指标权重值,一级指标权重:「人员队伍建设」0.2046、「实验室性能建设与维护」0.2023、「应急响应保障」0.1989、「核酸检测资源信息管理系统」0.1982、「区域移动核酸检测应急响应体系建设」0.1959。
证据类型、等级与局限
- 证据类型:改良德尔菲共识研究(BMC Health Serv Res)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为该评估体系提出具体、客观、可量化的评估标准,可作为多元化主体发现薄弱环节和漏洞的工具。
- 作者认为该体系可为主管部门提升核酸检测能力提供可测量依据。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Large-scale detection has great potential to bring benefits for containing the COVID-19 epidemic and supporting the government in reopening economic activities. Evaluating the true regional mobile severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus nucleic acid testing capacity is essential to improve the overall fighting performance against this epidemic and maintain economic development. However, such a tool is not available in this issue. We aimed to establish an evaluation index system for assessing the regional mobile SARS-CoV-2 virus nucleic acid testing capacity and provide suggestions for improving the capacity level.
METHODS: The initial version of the evaluation index system was identified based on massive literature and expert interviews. The Delphi method questionnaire was designed and 30 experts were consulted in two rounds of questionnaire to select and revise indexes at all three levels. The Analytic Hierarchy Process method was used to calculate the weight of indexes at all three levels.
RESULTS: The evaluation index system for assessing the regional mobile SARS-CoV-2 virus nucleic acid testing capacity, including 5 first-level indexes, 17 second-level indexes, and 90 third-level indexes. The response rates of questionnaires delivered in the two rounds of consultation were 100 and 96.7%. Furthermore, the authority coefficient of 30 experts was 0.71. Kendall's coordination coefficient differences were statistically significant (P < 0.001). The weighted values of capacity indexes were established at all levels according to the consistency test, demonstrating that 'Personnel team construction' (0.2046) came first amongst the five first-level indexes, followed by 'Laboratory performance building and maintenance' (0.2023), 'Emergency response guarantee' (0.1989), 'Information management system for nucleic acid testing resources' (0.1982) and 'Regional mobile nucleic acid testing emergency response system construction' (0.1959).
CONCLUSION: The evaluation system for assessing the regional mobile SARS-CoV-2 virus nucleic acid testing capacity puts forward a specific, objective, and quantifiable evaluation criterion. The evaluation system can act as a tool for diversified subjects to find the weak links and loopholes. It also provides a measurable basis for authorities to improve nucleic acid testing capabilities.
参考来源
- Di DS, Zhang JL, Wei MH, et al. An evaluation index system for regional mobile SARS-CoV-2 virus nucleic acid testing capacity in China: a modified Delphi consensus study. BMC Health Serv Res. 2022. PMID: 36002820. doi:10.1186/s12913-022-08446-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。